OICR researchers

OICR supports approximately 1,900 highly qualified personnel at institutions across the province of Ontario. This page lists the recipients of OICR Investigator Awards, Associates, research fellows and the leaders of OICR’s research programs and initiatives. Find out more about OICR’s Investigator Awards Program.

Jump to last name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sagi Abelson

Dr. Abelson studies the extrinsic selective pressures and cell-intrinsic mechanisms governing clonal dominance and cell transformation.

More details

Laurie Ailles

Dr. Ailles and her team are focusing on two major research areas: intra-tumoural heterogeneity and epigenetics in clear cell renal cell carcinoma.

More details

Rima Al-awar

Dr. Al-awar, Head of Therapeutic Innovation and Drug Discovery, discovers and develops new drugs for various cancers in collaboration with both academic and industry partners.

More details

Ken Aldape

Dr. Aldape is an OICR associate.

More details

Philip Awadalla

Dr. Awadalla and his team focus on the development of genomics approaches, model-based tools and population-based approaches to study mutation rates, genome biology and cancer.

More details

John Bartlett

Dr. Bartlett and his team focus on the development of novel diagnostic approaches to stratified medicine, predominantly in breast and prostate cancer.

More details

Philippe Bedard

Dr. Bedard is working to bring next-generation sequencing to more Ontario cancer patients through the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

More details

John Bell

Dr. Bell's lab is developing novel oncolytic virus products that both kill cancer cells while stimulating anti-tumour immunity.

More details

Marcus Butler

Dr. Butler is the clinical lead of OICR's Immuno-oncology Translational Research Initiative (ACTION). His expertise includes clinical trials in a variety of immune therapies.

More details

Tricia Cottrell

Tricia Cottrell

Dr. Tricia Cottrell is a clinician scientist whose research focuses on tumour-immune interactions in solid tumours.

More details

Janet Dancey

Dr. Janet Dancey is the leader of the Canadian Cancer Clinical Trials Network and the Canadian Cancer Trials Group.

More details

John Dick

Dr. Dick, who co-leads OICR's Acute Leukemia Translational Research Initiative, is a pioneer in cancer stem cell biology.

More details

Peter Dirks

Dr. Dirks is a pediatric neurosurgeon and senior scientist at the Hospital for Sick Children. He co-leads OICR's Brain Cancer Translational Research Initiative.

More details

Harriet Feilotter

Dr. Feilotter focuses on the development of biomarkers to be used in the screening, diagnosis or treatment of human diseases, including cancer.

More details

Aaron Fenster

Dr. Fenster is driven by the opportunity to use technological innovations to meet the challenges of cancer diagnosis and therapy needs. He co-leads OICR's Imaging program.

More details

Marc Fiume

Dr. Fiume is the CEO of DNAstack, a key leader within the Global Alliance for Genomics and Health and an OICR associate.

More details

Vincent Ferretti

Dr. Ferretti is a bioinformatics leader with experience in both large-scale software development and computational genomics.

More details →

Geoffrey T. Fong

Dr. Fong is the founder of the International Tobacco Control Policy Evaluation Project. This project's objective is to evaluate the impact of policies designed to control tobacco use.

More details

Steven Gallinger

Dr. Gallinger is the leader of OICR's Pancreatic Cancer Translational Research Initiative (PanCuRx).

More details

Eva Grunfeld

The focus of Dr. Grunfeld’s research is the evaluation of access to and quality of cancer care across the cancer control continuum – from screening to end-of-life care.

More details

Benjamin Haibe-Kains

Dr. Haibe-Kains is an OICR associate that works to develop tools that can mine pharmacogenomic datasets.

More details

Masoom Haider

Dr. Haider’s research focus is abdominal and pelvic MRI with an interest in therapeutic response assessment and quantitative imaging of cancer.

More details

Timothy Hanna

Dr. Hanna’s research focuses on three translational streams of health services research: quality of care, value of care and access to care.

More details

Naoto Hirano

The overarching goal of Dr. Hirano’s research is to devise novel anti-tumour immunotherapeutic modalities that can cure cancer.

More details

Kristin Hope

Dr. Hope aims to identify the underlying processes that lead to the transformation of healthy cells into leukemic cells and contribute to the progression of the disease.

More details

Tamara Jamaspishvili

Dr. Jamaspishvili is working to identify and validate promising diagnostic and prognostic biomarkers for early prostate cancer.

More details

Elizabeth Kornaga

Kornaga is an OICR associate working in molecular pathology.

More details

David LeBrun

Dr. LeBrun’s research group studies perturbations in the regulation of gene transcription that underlie acute lymphoblastic leukemia and other cancers.

More details

Mathieu Lupien

Dr. Lupien’s research highlights the need to characterize and understand the role of noncoding regulatory elements as targets of genetic and epigenetic changes in oncogenesis.

More details

John McPherson

Dr. McPherson is an OICR associate specializing in genome technologies.

More details

Quaid Morris

Dr. Morris is a Senior Investigator and an OICR associate specializing in machine learning and artificial intelligence.

More details

Brian Nieman

Dr. Nieman is studying the developmental impact of chemotherapy agents with a goal of improved brain development and quality of life in childhood cancer patients.

More details

Faiyaz Notta

Dr. Notta is an OICR associate working to decipher new molecular targets that are needed to treat pancreatic cancer.

More details

Amit Oza

Dr. Oza co-leads OICR's Ovarian Cancer Translational Research Initiative and specializes in clinical trials for gynecologic cancers.

More details

David Palma

Dr. Palma's research focuses on new imaging technologies used with radiotherapy to improve tumour targeting and to deliver higher doses of radiotherapy than previously possible.

More details

Anna Panchenko

Anna Panchenko

Dr. Panchenko's research group studies the genetic and epigenetic mechanisms of cancer, including the effects of mutations on protein activity, interactions and dynamics.

More details

Bret Pearson

Dr. Pearson’s lab is working to understand the connection between adult stem cells and cancer by using the freshwater planarian as an in vivo model system.

More details

Gregory Pond

Dr. Pond’s research interest is in statistical methodologies and analysis of cancer clinical trials, with an aim to facilitate the translation of scientific discoveries into the clinic.

More details

Trevor Pugh

Dr. Pugh is the Director of Genomics at OICR.

More details

Jüri Reimand

The Reimand Lab develops and applies methods to interpret cancer data using pathway and network information.

More details

Robert Rottapel

The Rottapel Lab uses functional genetic screens (both shRNA and CRISPR/Cas9) to identify novel vulnerabilities in ovarian cancer as a strategy to develop new therapeutic targets.

More details

Aaron Schimmer

Dr. Schimmer is the co-leader of OICR's Acute Leukemia Translational Research Initiative. His work focuses on new therapies for leukemia.

More details

Timothy Scholl

Dr. Scholl is focusing on developing an emergent technique for molecular imaging with magnetic resonance.

More details

Parisa Shooshtari

Parisa Shooshtari

Dr. Shooshtari develops computational and statistical methods to understand the cellular and molecular mechanisms underlying complex diseases.

More details

Jared Simpson

The Simpson Lab develops algorithms and software for the analysis of high-throughput sequencing data.

More details

Lillian Siu

Dr. Siu is Co-Principal Investigator of the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

More details

David Soave

Dr. Soave is an OICR associate specialized in biostatistics and longitudinal data analysis.

More details

Lincoln Stein

Dr. Stein is the leader of Adaptive Oncology at OICR.

More details

Michael Taylor

Dr. Taylor is a paediatric neurosurgeon and senior scientist at the Hospital for Sick Children. He co-leads OICR's Brain Cancer Translational Research Initiative.

More details

Brad Wouters

Dr. Wouters’ lab has identified new signaling pathways that influence how tumours respond to environments with reduced oxygenation.

More details

Martin Yaffe

Dr. Yaffe’s research is directed toward development and improvement of imaging techniques for the earlier detection, diagnosis and treatment of cancer.

More details

Christina Yung

Dr. Yung is the Director of Genome Informatics at OICR.

More details